Egypt, Kenya, Nigeria, Senegal, South Africa, and Tunisia will be the first six African countries to get the technologies needed to manufacture Moderna vaccines, according to the World Health Organization (WHO).
“At today’s European Union-African Union summit in Brussels, WHO Director-General Dr. Tedros Adhanom Ghebreyesus revealed the first six African countries to get the technology required to create mRNA vaccines. Egypt, Kenya, Nigeria, Senegal, South Africa, and Tunisia all applied and were chosen as recipients,” Dr. Tedros Adhanom Ghebreyesus, the Director-General, revealed the first six African countries to get the technology needed to create mRNA vaccines. Egypt, Kenya, Nigeria, Senegal, South Africa, and Tunisia all applied and were chosen as recipients, according to the World Health Organization.
According to the World Health Organization, the Moderna technology hub will assist vaccine makers by providing access to the essential operating procedures and know-how to mass-produce vaccines in compliance with international standards. The centre will also increase production capacity for other medical supplies that countries require to build their health systems, in addition to COVID-19 vaccines.
“The best way to address health emergencies and achieve universal health coverage in the mid- to long-term is to significantly increase the capacity of all regions to manufacture the health products they need, with equitable access as their primary endpoint,” said WHO chief Dr. Tedros Adhanom Ghebreyesus.
President Cyril Ramaphosa of South Africa said: “This is a project that would allow us to create our own vaccines, which is really essential to us. It entails mutual respect, acknowledgement of what we can all bring to the table, investments in our economies and infrastructure, and, in many ways, giving back to the continent.”
According to the announcement, the WHO and its African and European partners will work with the beneficiaries to build a plan and provide the necessary training and support so that the nations may begin vaccine manufacturing soon.
Despite the fact that COVID-19 vaccine supplies in Africa have expanded dramatically in recent months, immunisation rates on the continent remain quite low, with only roughly 11% of the population fully immunised.